                    &\multicolumn{1}{c}{All Trials}&\multicolumn{1}{c}{Phase I}&\multicolumn{1}{c}{Phase II}&\multicolumn{1}{c}{Phase III}\\
\hline
Number of trials receiving funding&            &            &            &            \\
No biomarker        &        1840&         647&         976&         217\\
                    &      (42.4)&      (25.2)&      (30.8)&      (14.6)\\
Biomarker           &        2198&         880&        1157&         161\\
                    &      (46.0)&      (28.9)&      (33.3)&      (12.6)\\
                    &\multicolumn{1}{c}{}&\multicolumn{1}{c}{}&\multicolumn{1}{c}{}&\multicolumn{1}{c}{}\\
\hline
Percent of trials receiving funding&            &            &            &            \\
No biomarker        &         2.1&         2.0&         2.7&         1.1\\
                    &      (0.05)&      (0.08)&      (0.08)&      (0.07)\\
Biomarker           &         3.7&         4.9&         4.2&         1.2\\
                    &      (0.08)&      (0.16)&      (0.12)&      (0.09)\\
\hline
Observations        &      146990&       49487&       64155&       33348\\
